Recent Progress of Molecular Design in Organic Type I Photosensitizers

Area of Science:

• Oncology
• Phototherapy
• Medicinal Chemistry

Background:

• Photodynamic therapy (PDT) is a promising non-invasive cancer treatment.
• Tumor hypoxia limits the efficacy of traditional reactive oxygen species-dependent PDT.
• Type I PDT, which relies on radical production with low oxygen dependence, is an emerging alternative.

Purpose of the Study:

• To systematically review recent advancements in the molecular design of organic type I photosensitizers (PSs).
• To provide a holistic understanding of design principles for type I PSs, particularly those utilizing electron transfer mechanisms.
• To offer insights for developing novel anti-hypoxia PDT strategies.

Main Methods:

• Systematic review of recent literature on organic type I photosensitizers.
• Categorization of molecular design strategies into three key approaches.
• Analysis of electron transfer-mediated type I PDT mechanisms.

Main Results:

• Identified three fundamental strategies for type I PS molecular design: modulating charge distribution, utilizing low triplet excited states to inhibit singlet oxygen, and inducing electron transfer for radical formation.
• Highlighted the importance of electron transfer mechanisms in type I PDT.
• Emphasized the potential of type I PDT to overcome tumor hypoxia.

Conclusions:

• Molecular design principles for type I PSs are becoming clearer, offering pathways for improved therapeutic efficacy.
• Further development of type I PSs holds significant promise for advancing anti-hypoxia PDT.
• This review provides valuable insights for future research in type I PS design and PDT applications.